In less than a year, Graphite sped from series A to Wall Street as it looks to fund its gene-editing treatments for sickle cell and other diseases.
Chilean researchers have repurposed a carbon dioxide detector model to warn of the risk of contracting COVID-19 in enclosed spaces.